Citadel Advisors
KPRX icon

Citadel Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History

Citadel Advisors’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
116,011
+66,478
+134% +$167K ﹤0.01% 11083
2026
Q1 		$95.6K Buy
49,533
+27,152
+121% +$57.3K ﹤0.01% 12053
2025
Q4 		$44.1K Sell
22,381
-22,192
-50% -$50.6K ﹤0.01% 12088
2025
Q3 		$125K Buy
+44,573
New +$122K ﹤0.01% 11677
2025
Q2 		– Sell
-26,550
Closed -$79.9K – 13900
2025
Q1 		$79.9K Buy
+26,550
New +$92.2K ﹤0.01% 11763
2024
Q4 		– Sell
-10,114
Closed -$37K – 14975
2024
Q3 		$37K Buy
+10,114
New +$39.5K ﹤0.01% 12237
2024
Q1 		– Sell
-10,287
Closed -$49.1K – 15065
2023
Q4 		$49.1K Buy
+10,287
New +$53.4K ﹤0.01% 11797
2023
Q2 		– Sell
-1,570
Closed -$47.2K – 14827
2023
Q1 		$47.2K Buy
+1,570
New +$58.7K ﹤0.01% 12232
2022
Q3 		– Sell
-129
Closed -$22K – 13145
2022
Q2 		$22K Buy
+129
New +$21.6K ﹤0.01% 12362
2021
Q3 		– Sell
-59
Closed -$77K – 14266
2021
Q2 		$77K Buy
59
+3
+5% +$4.66K ﹤0.01% 13100
2021
Q1 		$100K Buy
+56
New +$122K ﹤0.01% 12473
2019
Q1 		– Sell
-9
Closed -$22K – 9608
2018
Q4 		$22K Buy
9
+2
+29% +$4.62K ﹤0.01% 8706
2018
Q3 		$11K Buy
7
+2
+40% +$5.37K ﹤0.01% 9103
2018
Q2 		$14K Sell
5
-5
-50% -$14.1K ﹤0.01% 8698
2018
Q1 		$22K Buy
10
+4
+67% +$17.3K ﹤0.01% 8105
2017
Q4 		$34K Buy
+6
New +$37.1K ﹤0.01% 7741

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors's KPRX Position: Q2 2026 in Review

Citadel Advisors increased its Kiora Pharmaceuticals (KPRX) stake by 134% in Q2 2026, buying an estimated $167K and bringing the position to 116,011 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #11083.

Citadel Advisors first reported a position in KPRX in Q4 2017 and has held it in 16 quarters since. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Citadel Advisors held 116,011 shares of Kiora Pharmaceuticals worth $305K as of Q2 2026.
  • Citadel Advisors bought 66,478 Kiora Pharmaceuticals shares in Q2 2026, an estimated $167K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11083 holding.
  • Citadel Advisors first reported a position in Kiora Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.